Suzuki T, Ishikawa S, Motoyama T, Oboshi S
Acta Pathol Jpn. 1980 Jul;30(4):557-64. doi: 10.1111/j.1440-1827.1980.tb01351.x.
Leupeptins, protease inhibitors, suppress the appearance of experimental amyloidosis in CBA mice induced by the injections with complete Freund's adjuvant. This substance, however, should be administered continuously from 1 week prior to amyloid induction to the end of the experiment. On the other hand, Trypan blue, inhibitors of lysosomal enzymes, accelerates experimental amyloidosis in the mouse model above-mentioned. Trypan blue is effective when given either prior to or at the same time of the initiation of amyloid induction. Organic Germanium has not been confirmed to be a potent suppressor of experimental murine amyloidosis but the experimental group administered this substance continuously from 1 week prior to the induction shows a rather low incidence of amyloidosis, and the average number of amyloidotic organs per affected mouse is about half of that of the control group. The suppression and acceleration of experimental murine amyloidosis presented here are a useful tool for investigating the pathogenesis of amyloidosis.
亮肽素是一种蛋白酶抑制剂,可抑制用完全弗氏佐剂注射诱导的CBA小鼠实验性淀粉样变性的出现。然而,这种物质应在淀粉样变性诱导前1周开始持续给药直至实验结束。另一方面,溶酶体酶抑制剂台盼蓝会加速上述小鼠模型中的实验性淀粉样变性。台盼蓝在淀粉样变性诱导前或诱导开始时给药均有效。有机锗尚未被确认为实验性小鼠淀粉样变性的有效抑制剂,但从诱导前1周开始持续给予该物质的实验组淀粉样变性的发生率相当低,且每只患病小鼠的淀粉样变性器官平均数量约为对照组的一半。本文介绍的实验性小鼠淀粉样变性的抑制和加速是研究淀粉样变性发病机制的有用工具。